The TISIDB database assessed that CX3CR1 gene expression was significantly associated with immunoinhibitors in epithelial ovarian cancer, including HAVCR2 (R = 0.51, P < 2.2e−16) and CSF1R (R = 0.66, P < 2.2e−16; Fig. 6B). The gene discussed is CX3CR1; the disease is ovarian carcinoma.